Results 131 to 140 of about 30,945 (225)

The Postprandial Chronobiome in Interorgan Glucose Homeostasis

Comprehensive Physiology, Volume 16, Issue 4, August 2026.
The postprandial chronobiome framework proposes that meal‐timed oscillations in microbial communities and metabolites may interact with host tissue clocks to shape glucose handling. The liver is the best‐supported temporal interpreter, while phase‐aware human studies are needed to establish causal interorgan effects.
Josko Bozic, Roko Santic, Marko Kumric
wiley   +1 more source

Analysis of the Clinical Application Value of Immune Function Markers and Cytokines in the Recurrent Aphthous Ulcer

Clinical and Experimental Dental Research, Volume 12, Issue 4, August 2026.
ABSTRACT Background This study aimed to analyze the alterations in cellular and humoral immune functions, alongside cytokine profiles, in patients with recurrent aphthous ulcer (RAU) compared to those with other oral mucosal diseases and healthy controls (HC), and to investigate their clinical significance.
Yiwen Chen, Ting Meng, Lahong Zhang, Qiang Ke   +3 more
wiley   +1 more source

Identification of VEGFB associated with NKT cells in diabetic foot ulcers: Single-cell analysis and machine learning. [PDF]

Medicine (Baltimore)
Wang W, He Y, You T, Lei M, Chen J.
europepmc   +1 more source

TCF/LEF family transcription factors: Molecular landscape and prognostic scoring in pan‐cancer

Clinical and Translational Discovery, Volume 6, Issue 4, August 2026.
This study provides a comprehensive molecular landscape of TCF/LEF family transcription factors across 33 cancer types. We developed a TCF/LEF‐based prognostic score that correlates with immune infiltration, metabolic reprogramming and drug sensitivity, offering a robust transcriptomic signature for predicting patient survival and therapeutic response.
Zhengjun Yang, D. Q. Cai, Zhen Zhao, Zhixiang Jian, Mude Shi, Yajin Chen, Jueming Chen, Chunhua Qu, Diankui Cai   +8 more
wiley   +1 more source

The Dual Role of the Gut Microbiota in Cancer Chemoresistance

MicrobiologyOpen, Volume 15, Issue 4, August 2026.
Comparison between Microbiota and Cancer therapy. ABSTRACT Chemoresistance is one of the primary reasons that cancer chemotherapy fails to deliver successful treatment outcomes and contributes to poor overall survival rates for patients with cancer. New research has begun to shed light on the effects of the gut microbiome (GM).
Hamed Tahmasebi, Aisa Bahar, Meisam Khazaei, Mohammad Reza Arabestani   +3 more
wiley   +1 more source

Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell-engineered mesothelin-redirected CAR-NKT cells. [PDF]

Proc Natl Acad Sci U S A
Li YR, Shen X, Zhu E, Li Z, Huang J, Le T, Tran C, Radu CG, Yang L.   +8 more
europepmc   +1 more source

Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy

MedComm, Volume 7, Issue 8, August 2026.
Barrier‐defined strategies for cold‐to‐hot tumor conversion. Cold tumors include immune‐desert and immune‐excluded states marked by poor antigen visibility, limited T‐cell priming, stromal or vascular exclusion, metabolic stress and suppressive immune programs.
Xiao Ge, Dong Han, Jing Wang, Xinyu Dai, Chen Ma, Feihong Chen   +5 more
wiley   +1 more source

Invariant and Diverse NKT Cells Regulate Bacterial Clearance and Pathology in Chlamydial Genital Tract Infection in Mice. [PDF]

Pathogens
Ishii K, Soejima T, Ohnishi Y, Ozuru R, Itoh R, Chou B, Yoshimura M, Shimizu A, Kurihara Y, Sakamoto A, Hiromatsu K.   +10 more
europepmc   +1 more source

Pathogenic NKT cells attenuate urogenital chlamydial clearance and enhance infertility. [PDF]

Scand J Immunol, 2023
Armitage CW, Carey AJ, Bryan ER, Kollipara A, Trim LK, Beagley KW.   +5 more
europepmc   +1 more source

Editorial: NKT Cells in Cancer Immunotherapy [PDF]

Frontiers in Immunology, 2020
Tonya J. Webb, Weiming Yuan, Everett Meyer, Paolo Dellabona   +3 more
openaire   +3 more sources